|
Volumn 9, Issue 3, 2008, Pages 295-300
|
11β-hydroxysteroid dehydrogenase type 1 inhibitors for metabolic syndrome
|
Author keywords
11 HSD1; Dyslipidemia; Glucocorticoid; Hypertension; Insulin resistance
|
Indexed keywords
11BETA HYDROXYSTEROID DEHYDROGENASE;
3 CHLORO 2 METHYL N [4 [2 (4 METHYL 1 PIPERAZINYL) 2 OXOETHYL] 2 THIAZOLYL]BENZENESULFONAMIDE;
AMG 221;
CARBENOXOLONE;
GLUCOSE;
HE 3286;
INCB 13739;
LIPID;
OXIDOREDUCTASE INHIBITOR;
ROSIGLITAZONE;
UNCLASSIFIED DRUG;
ENZYME INHIBITOR;
BLOOD PRESSURE;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG SELECTIVITY;
DRUG TARGETING;
ENZYME ACTIVITY;
ENZYME ANALYSIS;
ENZYME INHIBITION;
ENZYME MECHANISM;
GENE EXPRESSION;
GLUCONEOGENESIS;
GLUCOSE HOMEOSTASIS;
GLYCEMIC CONTROL;
HUMAN;
HYPERTENSION;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIPID BLOOD LEVEL;
LIPID DIET;
LIPID METABOLISM;
LIPID OXIDATION;
METABOLIC DISORDER;
METABOLIC SYNDROME X;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OBESITY;
PROTEIN EXPRESSION;
REVIEW;
ANIMAL;
DRUG ANTAGONISM;
ENZYMOLOGY;
HOMEOSTASIS;
METABOLISM;
PATHOPHYSIOLOGY;
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1;
ANIMALS;
ENZYME INHIBITORS;
GLUCOSE;
HOMEOSTASIS;
HUMANS;
HYPERTENSION;
LIPID METABOLISM;
METABOLIC SYNDROME X;
OBESITY;
|
EID: 40049094652
PISSN: 14724472
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (24)
|
References (69)
|